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Abstract
The mammalian Pcdhg gene cluster encodes a family of 22 cell adhesion molecules, the
gamma-Protocadherins (γ-Pcdhs), critical for neuronal survival and neural circuit formation.
The extent to which isoform diversity–a γ-Pcdh hallmark–is required for their functions
remains unclear. We used a CRISPR/Cas9 approach to reduce isoform diversity, targeting
each Pcdhg variable exon with pooled sgRNAs to generate an allelic series of 26 mouse
lines with 1 to 21 isoforms disrupted via discrete indels at guide sites and/or larger deletions/
rearrangements. Analysis of 5 mutant lines indicates that postnatal viability and neuronal
survival do not require isoform diversity. Surprisingly, given reports that it might not indepen-
dently engage in trans-interactions, we find that γC4, encoded by Pcdhgc4, is the only criti-
cal isoform. Because the human orthologue is the only PCDHG gene constrained in
humans, our results indicate a conserved γC4 function that likely involves distinct molecular
mechanisms.
Author summary
The γ-Protocadherins (γ-Pcdhs) are a family of 22 molecules that serve many crucial func-
tions during neural development. They can combine to form multimers at the cell surface,
such that each combination specifically recognizes the same combination at the surface of
other cells. In this way, 22 molecules can generate thousands of distinct recognition com-
plexes. To test the extent to which molecular diversity is required for the γ-Pcdhs to serve
their many functions, we used CRISPR/Cas9 gene editing to make a series of mouse
mutants in which different combinations of the γ-Pcdhs are disrupted. We report 25 new
mouse lines with between 1 and 21 intact members of the γ-Pcdh family. Further, we
found that for the critical function of neuronal survival–and consequently the survival of
the animal–the molecular diversity was not essential. Rather, a single member of the fam-
ily called γC4 was the only one necessary or sufficient for this function; databases of
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human genome sequences suggest that this important role is conserved. These new strains
will be invaluable for disentangling the role of molecular diversity in the γ-Pcdhs’ func-
tions, and as we have already found, will help identify specific functions for specific γ-
Pcdh family members.
Introduction
Cell-cell recognition via transmembrane cell adhesion molecules is essential for neural cir-
cuit formation. With trillions of exquisitely specific synapses in the human brain, it has been
suggested that molecular diversity–achieved either via alternative gene splicing or combina-
torial expression of large adhesion molecule families–plays an important role [1]. In mam-
mals, this is exemplified by the clustered protocadherins (cPcdhs). The cPcdhs, expressed
broadly throughout the developing central nervous system (CNS), are cadherin superfamily
molecules that engage in strictly homophilic trans-interactions. The cPcdh isoforms are
encoded by three gene clusters arrayed in tandem at human chromosome 5q31 (encoding 53
cPcdh proteins) and on mouse chromosome 18 (encoding 58 cPcdh proteins)[2, 3]. In
mouse, the Pcdha cluster encodes 14 α-Pcdhs, the Pcdhb cluster encodes 22 β-Pcdhs, and the
Pcdhg cluster encodes 22 γ-Pcdhs (Fig 1A). While all three Pcdh gene clusters contribute to
neural development to some extent [4–10], the Pcdhg locus is the only one required for post-
natal viability, and disruption of this locus results in the strongest phenotypes (reviewed in
[11]).
The Pcdhg cluster is comprised of 22 variable (V) exons, divided according to sequence
homology into A, B, and C subgroups, and three constant exons. Each V exon is regulated by
an individual promoter and, upon transcription, is spliced to the constant exons [12, 13](Fig
1B). Each V exon encodes one γ-Pcdh isoform’s extracellular domain, including 6 cadherin
(EC) domains, a transmembrane domain, and a membrane-proximal variable cytoplasmic
domain (VCD), while the constant exons encode a C-terminal cytoplasmic domain common
to all 22 γ-Pcdh isoforms (Fig 1B). Single-cell RT-PCR from cerebellar Purkinje neurons indi-
cated that each neuron expressed all three γC isoforms (Pcdhgc3, Pcdhgc4, and Pcdhgc5) from
both alleles while stochastically expressing ~4 of the 19 γA and γB isoforms monoallelically
[14]. Interestingly, this does not hold in all neurons: single-cell transcriptomics performed on
serotonergic neurons indicated that αC2 was the dominant cPcdh, many neurons expressed
no Pcdhg genes, few if any expressed γC3 or γC5, and some expressed only γC4 [4]. Addition-
ally, few single olfactory sensory neurons were found to express any of the C-type Pcdha or
Pcdhg isoforms [5].
Clustered Pcdh isoforms interact strictly homophilically in trans, engaging in anti-parallel
interactions involving EC1-EC4, while EC5 and EC6 mediate promiscuous cis dimer forma-
tion between γ isoforms, as well as with α- and β-Pcdhs [15–19]. These two types of interac-
tions result in a multimeric lattice of dimers between cell membranes sharing the same
isoform composition [20, 21], and indeed, homophilic specificity is observed at the multimer
level [18, 19]. In this way, the 58 cPcdh isoforms generate thousands of distinct recognition
signals. This molecular diversity is paralleled in Drosophila by the gene Dscam1, which gener-
ates 38,016 distinct protein isoforms through alternative splicing [22]. Dscam1 isoform diver-
sity is essential for neurodevelopmental processes including axon guidance, synapse
specificity, and neurite self-avoidance [23–25](reviewed in [26]). Mammalian Dscams, despite
important roles in neurodevelopment, do not generate such isoform diversity [27–30].
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Fig 1. CRISPR/Cas9 strategy to reduce Pcdhg isoform diversity. A) A schematic of the clustered Pcdh loci with Pcdha, Pcdhb and
Pcdhg arrayed in tandem. Constant exons for Pcdha are in gray and those for Pcdhg in black. The homologous C variable (V) exons are
indicated by purple boxes. B) The Pcdhg cluster is comprised of 22 V exons and 3 constant exons. The V exons are subdivided into γA,
γB and γC groups based on sequence homology. sgRNA were designed to target each V exon (red asterisks). As shown for Pcdhgb2 as
an example, each V exon has its own promoter, and upon transcription, is spliced to the three constant exons. In the resulting protein,
the extracellular domain (cadherin repeats EC1-EC6), the transmembrane domain (TM) and variable cytoplasmic domain (VCD) are
encoded by the single V exon, while the C-terminal constant domain (Con) is encoded by the three constant exons. C) Examples for
Pcdhgb2 and Pcdhga11 indicate the general design strategy for sgRNA, targeting downstream of and proximal to the start codon. An
example mutation in Pcdhga11 (generated in the Pcdhgem6 allele) leads to a premature stop codon. D) The workflow for generating an
allelic series of mutants with reduced Pcdhg isoform diversity. Values indicate the number of mice–total or from each sgRNA injection
concentration–screened at each step.
https://doi.org/10.1371/journal.pgen.1008554.g001
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While α, β and γ isoforms can all contribute to multimer formation [21], the γ-Pcdhs are
particularly critical for neural development [11]. Mice lacking either the entire Pcdhg cluster
or the γC3-C5 V exons exhibited neonatal lethality, with excessive apoptosis of neuronal sub-
types in the spinal cord and hypothalamus [31–34]. Pcdhg mutants also exhibited reduced syn-
apse number and disorganized synaptic terminals within the spinal cord, which were separable
from the increased cell death [35–37]. When neonatal lethality was circumvented with a condi-
tional Pcdhg allele, distinct phenotypes were observed in other parts of the CNS, including
reduced dendrite arborization in forebrain neurons [38–41] accompanied by an increase in
morphologically immature dendritic spines [42]. In retina-restricted mutants, many neuronal
subtypes exhibited excessive cell death without separable synaptic disorganization [10, 43].
Starburst amacrine cells (SACs), however, survived in normal numbers, but exhibited clump-
ing of their dendritic fields, indicative of a failure of self-avoidance [44, 45].
The parallel molecular and phenotypic diversity of cPcdhs could, a priori, indicate three
potential models, all of which may be correct for distinct subsets of neurons or distinct func-
tions. First, isoform diversity per se may be required. Second, there may be a high level of iso-
form redundancy such that any one (or few) isoform(s) may suffice. Third, there may be
unique roles for individual isoforms, such that no other isoform can compensate for their loss.
Some evidence exists for each of these possibilities. The γC3-5 isoforms, but not γA1-3, were
required for postnatal viability in mice [34]. As γC5 is expressed later in the postnatal period
[46], and γC4 is unable to localize to the cell membrane alone (it requires carrier isoforms
from among the β- and other γ-Pcdhs) [17, 18, 47], it seemed most likely that this reflected a
crucial role for γC3. While re-expressing a single γ-Pcdh isoform (γA1 or γC3) could rescue
self-avoidance in SACs, it disrupted self/non-self recognition required for proper receptive
field overlap and retinal circuit performance [44, 45]. Similar re-expression of γA1 or γC3 in
cortical neurons on a Pcdhg null background led to aberrantly increased or decreased dendrite
arborization, depending on whether surrounding cells also expressed the same single isoform
and could thus presumably engage homophilically [40]. A requirement for cPcdh diversity per
se was discovered for the convergence of olfactory sensory neuron axons on particular glomer-
uli in the olfactory bulb: disruption of olfactory circuitry was mild in single gene cluster
mutants, but devastating in mice lacking all three clusters, and it was not rescued by re-
expressing a triad of single α-, β-, and γ-Pcdh isoforms [5, 48]. Support for unique roles for
individual cPcdh isoforms comes from the demonstration that the disrupted axonal branching
observed in Pcdha mutant serotonergic neurons [8] is due entirely to the role of one isoform,
αC2 (the dominant isoform expressed in these neurons) [4], and from the demonstration of a
unique role for γC3 in regulating Wnt signaling through Axin1 [49].
Thus, no single model is likely to encompass all of the γ-Pcdhs’ diverse functions. Addition-
ally, most prior studies have relied on mis- or over-expression of individual isoforms, which
could in some cases result in new, distinct phenotypes. In the first part of the present study,
and paralleling approaches establishing the necessity of Dscam1 molecular diversity for specific
neurodevelopmental roles in Drosophila [23–26], we used CRISPR/Cas9 genome editing to
simultaneously target the 22 Pcdhg variable exons in an unbiased manner, creating a new alle-
lic series of mouse mutants with reduced isoform diversity from the endogenous gene cluster.
In the second part of the present study, we find that only one isoform, γC4, is strictly required
for postnatal viability and survival of the many neuronal subsets shown previously to depend
on the γ-Pcdhs. Our results: 1) show that some γ-Pcdh functions do not require molecular
diversity; 2) confirm that at least some γ-Pcdh isoforms have unique roles; and 3) suggest that
the regulation of neuronal survival may require novel mechanisms of cPcdh interaction and/
or signaling involving γC4.
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Results
CRISPR/Cas9 strategy for reducing Pcdhg isoform diversity
To assess the importance of γ-Pcdh isoform diversity to postnatal viability and neurodevelop-
mental functions, we used a shotgun CRISPR/Cas9 genome editing screen to disrupt varying
numbers of Pcdhg variable exons (Fig 1B–1D). We reasoned that by injecting pooled individ-
ual single guide RNAs (sgRNAs) targeting each V exon into many zygotes, we could generate a
number of unique mutant mouse lines, each of which harbored distinct patterns of reduced
isoform diversity due to variability in which sgRNAs efficiently bound and directed mutations.
We designed sgRNAs to target within ~100–150 base pairs downstream of the start codon of
each Pcdhg V exon, with the goal of creating frame-shifting mutations through non-homolo-
gous end joining (NHEJ) repair (Fig 1B and 1C)[50, 51]. A total of twenty guides were
designed; the PcdhgB4 and PcdhgB5 V exons shared enough homology to allow a single guide
to target both, as did PcdhB6 and PcdhgB7. Pooled sgRNAs were concentrated, then combined
with Cas9 mRNA and microinjected into C57BL/6J mouse zygotes at three different concen-
trations (each individual guide at 50 ng sgRNA/μl, 10 ng sgRNA/μl, or 5 ng sgRNA/μl: HI,
MED, and LO, respectively), as described in Materials and Methods (Fig 1D). Microinjected
zygotes were transferred into a total of 20 pseudopregnant females, resulting in 100 live-born
mice (16 from HI, 34 from MED, and 50 from LO). All 100 founders were screened at 7 Pcdhg
exons by PCR with Sanger sequencing to detect frame-shifting mutations. From this initial
screen, 15 founders exhibited some disruption (10 from HI and 5 from MED) and were desig-
nated for breeding. Most disruptions were found in pups from HI or MED injections, so the
50 founders resulting from the LO injections were not pursued further. The remaining 35
founders were further screened by PCR and Sanger sequencing at the remaining 15 Pcdhg vari-
able exons. In this way, a total of 31 founders were identified that carried some constellation of
mutations at the guide-targeted sites (14/16 HI, 17/34 MED).
Due to the likely mosaicism of the founders and the uncertainty of germline transmission
of any given mutation, we did not characterize the 31 identified founders more extensively.
Rather, each was crossed with wild-type C57BL/6J animals to generate G1 offspring for further
analysis (Fig 1D). Sperm from male G1 mice was cryopreserved while somatic tissue was used
for genotyping to identify lines of interest carrying reduced diversity of Pcdhg variable exons.
Ninety-four G1 offspring were screened for heterozygous mutations using a custom amplicon
assay from Illumina and Illumina MiSeq sequencing (see Materials and Methods for details,
target coordinates are listed in the S1 File). The amplicon assay was designed to sequence the
22 Pcdhg sgRNA target regions, all the analogous regions in the untargeted Pcdha and Pcdhb
clusters, and the top 95 predicted potential off-target sites (Fig 1D). We screened for missense
and nonsense mutations, small indels and, because our approach was intended to produce up
to 22 double-stranded breaks within 160 kilobases, larger rearrangements between break-
points. Smaller indels were identified using the Genome Analysis Toolkit (GATK) [52], while
larger rearrangements were identified with BreaKmer [53]. Twenty-six distinct lines carrying
unique constellations of mutations are represented in Table 1, derived from 12 different foun-
ders (nucleotide sequences for mutations are listed in the S2 File). Most mouse lines (20 lines
from 9 founders) resulted from microinjection of the highest concentration of total sgRNAs
(50 ng/μl/guide). Mutations ranged from only one disrupted V exon (leaving 21 intact) to 21
disrupted V exons (leaving only 1 intact; Table 1). Each V exon was disrupted in at least one
mouse line, either by discrete indels, or through involvement in a rearrangement between
breakpoints.
Reducing diversity in the Pcdhg gene cluster
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Whole genome sequencing reveals rearrangements undetected by amplicon
sequencing
Based on initial results from the custom amplicon assay, we chose three lines for cryo-recovery
and further analysis–Pcdhgem5, Pcdhgem12, and Pcdhgem35 (Table 1). Mice from each recovered line
were intercrossed to generate homozygous mutants. Once obtained, we used these homozygous
mutants to verify by PCR V-exon indels and rearrangements. We found that fewer exons were
successfully amplified by PCR than expected (S1A Fig), indicating that amplicon sequencing failed
to detect all the mutations harbored by the heterozygous G1 mutants. Therefore, we performed
whole genome linked-read sequencing on homozygous mutants, using the Chromium Genome
Sequencing Solution from 10X Genomics to detect large scale rearrangements (S1 Fig, S2 Fig).
Paired-end reads from the whole genome sequencing were used to reconstruct the rearrange-
ments (Fig 2). We found that Pcdhgem5 contained frame-shifting indels in V exons A1, B1, A5,
A7, B7, and C4, all of which were accurately called by the prior amplicon sequencing. However,
there was an inversion and deletion that disrupted exons A9, B6, and A10 that was undetected by
the previous analysis (S2A Fig). Thus, Pcdhgem5 retained 13 intact V exons (Fig 2A), and we
renamed the allele Pcdhg13R1; “13R” for the number of intact exons remaining and “1” as it was
the first allele identified with this number (referred to as 13R1 hereafter for simplicity).
Table 1. Summary of Pcdhg exons disrupted in CRISPR/Cas9 targeted strains. Individual mouse lines are summarized with the allele name along with the name used
to describe the lines analyzed here. Red boxes indicate disrupted exons–"X” for discrete frame-shifting indel and dashed lines for large scale rearrangements or deletions
between the indicated exons. “IF” indicates an in-frame indel predicted to result in an expressed protein.
Allele Name here A1 A2 A3 B1 A4 B2 A5 A6 A7 B4 A8 B5 A9 B6 A10 B7 A11 B8 A12 C3 C4 C5 Intact exons
Pcdhgem4 X X X 19
Pcdhgem5 13R1 X X X X [– — –] X X 13
Pcdhgem6 [– — –] IF X IF X IF 17
Pcdhgem7 X X X 19
Pcdhgem8 1R1 [– — — — — — — — — — — — — — — — — — — –] X 1
Pcdhgem9 [– — — — — — –] IF X IF X 13
Pcdhgem10 IF X IF IF X 20
Pcdhgem11 IF X 21
Pcdhgem12 3R1 [– — — — –] X [– — — — — — — — — — — — –] 3
Pcdhgem13 X X X X 18
Pcdhgem14 X X X X 18
Pcdhgem16 X X X 19
Pcdhgem17 [– — — — — — –] IF X X 13
Pcdhgem19 [– — — — — — — — — — — — — — –] X 6
Pcdhgem23 [– — — — — — — — –] 13
Pcdhgem24 X 21
Pcdhgem25 X X X [– — –] 16
Pcdhgem27 [– — — — — — — — — –] 12
Pcdhgem28 X X X 19
Pcdhgem31 X X IF IF X 19
Pcdhgem32 IF [– — — — –] X 16
Pcdhgem33 X X [– — — — –] [– — — — — — — — –] X 5
Pcdhgem34 [– — — — — — –] IF IF X 14
Pcdhgem35 3R2 [– — — — — — — — — — — — — — — — –] X IF X 3
Pcdhgem42 X IF 21
Pcdhgem44 X 21
Pcdhgem41 C4KO X 21
https://doi.org/10.1371/journal.pgen.1008554.t001
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Sequencing of Pcdhgem12 revealed extensive rearrangements. A fusion between exons A5
and B8 identified by the amplicon sequencing was confirmed, but additional junctions were
found between A1 and A4, between A12 and A9, and between B6 and A6 (Fig 2A, S1C Fig).
Fig 2. Three new Pcdhg alleles with reduced isoform diversity via CRISPR/Cas9 genome editing. Schematics of the mutated Pcdhg alleles
verified or identified by whole genome sequencing in three strains illustrate the range of mutations induced by CRISPR/Cas9 targeting. A) In 13R1
mutants, frame-shifting indels disrupted 6 exons (upward triangle indicates insertion, downward indicates deletion, red indicates frame-shift) and
an inversion and deletion disrupted exons A9, B6, and A10. B) In 3R1 mutants, there was a small frame-shifting insertion in exon B2 along with
multiple deletions and rearrangements between exons. For example, genomic DNA between the exon A5 and exon A6 guide sites was inverted and
inserted at the B6 guide site, followed by coding sequence from the gene Anp32a (purple box) and a transposable element (green box). Only exons
C3, C4, and C5 remain intact. C) In 3R2 mutants, a single large deletion resulted in a fusion between guide sites at exon A1 and exon A11. This was
accompanied by small, frame-shifting deletions in exons A12 and C5 and a small in-frame deletion in exon C4 (downward pointing green
triangle).
https://doi.org/10.1371/journal.pgen.1008554.g002
Reducing diversity in the Pcdhg gene cluster
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Furthermore, linked reads revealed an insertion including a transposable element and coding
sequence from Anp32a which aligns to exons 4–7 of transcript Anp32a-201 without the interven-
ing introns (Fig 2B, S1D Fig). This phenomenon of the insertion of a transposable element along
with coding sequence from an early expressed gene has been previously described in CRISPR
genome editing [54]. As this sequence was inserted 3’ to the inverted exon Pcdhga5, there is no
associated transcription start site, and no protein product is expected. Altogether, at least 9 dou-
ble-stranded breaks occurred, resulting in a frame-shifting 52 bp insertion into exon B2, and
larger deletions and rearrangements disrupting all the other γA and γB isoforms. As only the 3 γC
V exons remained intact in Pcdhgem12, we renamed this allele Pcdhg3R1 (3R1 hereafter; Fig 2B).
Whole genome sequencing from Pcdhgem35 mutants confirmed small frame-shifting dele-
tions at exons A12 and C5, as well as an in-frame deletion of 9 bp in exon C4. However, this
more exhaustive sequencing also revealed a large rearrangement undetected by the prior
amplicon sequencing analysis. Here, there was a ~94 kb deletion spanning the breakpoint
from exon A1 to that of exon A11 (S2B Fig). Only exons B8 and C3 were unaffected by any
mutation. As exon C4 still encoded a nearly full-length protein lacking only 3 amino acids (res-
idues 27–29 in the signal peptide), we renamed the Pcdhgem35 allele Pcdhg3R2 (3R2 hereafter,
Fig 2C), as it represented the second allele identified with 3 isoforms remaining.
In all three mutants analyzed thus far, rearrangements were identified by whole genome
sequencing that were undetected by the amplicon analysis (Fig 2, S1 Table). With this informa-
tion, we re-analyzed the amplicon sequencing data by visual inspection of the paired reads
within the Integrative Genomics Viewer (IGV). We were able to find many, but not all, of the
junctions identified by the whole genome sequencing, but missed by BreaKmer analysis of the
amplicon sequencing (S1B Fig). Therefore, we manually inspected the alignments from each
of the other frozen lines. Additional rearrangements were identified where each of the paired
ends of multiple reads mapped to different exons (S1 Table).
Isoform diversity per se is not required for postnatal viability
The complete deletion of the Pcdhg cluster results in neonatal lethality [33], as does the dele-
tion of the three γC V exons, whereas mice with deletion of the first three γA exons (A1, A2,
A3) had no reported phenotypes [34]. Of the three lines initially characterized, 3R1 and 3R2
homozygous mutant mice were born at expected Mendelian ratios and survived into adult-
hood without any overt differences from their wild-type or heterozygous littermates. In con-
trast, 13R1 homozygous mutants died within hours of birth with the hunched posture, tremor,
and inability to right themselves or nurse that is characteristic of Pcdhgdel/del mutants lacking
the entire Pcdhg cluster [33, 37]. Whole genome sequencing from all three lines confirmed that
there were no off-target mutations in the Pcdha or Pcdhb locus, or any disruptions in the
Pcdhg constant exons. However, it remained formally possible that the particular rearrange-
ments within 13R1 mutants disrupted the expression of the other isoforms or V exon splicing
to the constant exons, creating a functional null mutation.
To exclude this possibility, we performed quantitative real-time PCR using cDNA from the
cerebral cortices of homozygous mutants and wild-type littermates (Fig 3A). To detect specific
isoform transcripts, forward primers targeting the 3’ end of each V exon were used with a
reverse primer in constant exon 1 (product spans 1 intron) or exon 2 (product spans 2
introns). To monitor total levels of Pcdhg locus transcription, a forward primer in constant
exon1 was used with a reverse primer in constant exon 2 (spanning 1 intron, primer sequences
in S2 Table). Total locus expression was significantly reduced in 3R2 homozygous mutants,
but in both 3R1 and 13R1 mutant cortex, expression differences did not reach statistical signif-
icance. Furthermore, individual isoform transcription was reduced significantly only when
Reducing diversity in the Pcdhg gene cluster
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mutations completely disrupted the exon by deletion or inversion. Smaller indels generally
had no effect on transcript expression level (e.g., A1, B1, A5, A7, B7, and C4 were not signifi-
cantly reduced in 13R1 homozygous mutants, but A9, B6, and A10 were undetectable). Addi-
tionally, transcription of several V exon fusions was detected, including A4 (fusion with A1)
and A9 (fusion with A12) in 3R1 (predicted protein products encoded by these fused tran-
scripts are listed in S2 File). We also asked the extent to which mutations within the Pcdhg
locus altered isoform transcription from the Pcdha or Pcdhb clusters. While there were no sig-
nificant changes detected in 13R1 mutants, isoforms from the 3’ end of the Pcdhb locus were
expressed at significantly higher levels in 3R1 and 3R2 homozygous mutants compared to con-
trols (β11 in 3R1, β15 and β22 in both 3R1 and 3R2). Expression of Pcdha cluster genes
appeared to be unchanged (S3 Fig).
Fig 3. Pcdhg isoform expression reflects genomic locus status in CRISPR/Cas9 mutant lines. A) Quantitative RT-PCR analysis of cerebral
cortex cDNA from 13R1 mutants (red), 3R1 mutants (blue) and 3R2 mutants (green) verified that intact isoforms were expressed at expected
levels. Expression of constant exons was significantly reduced in 3R2 mutants only. 13R1 mutants were analyzed at P0, while 3R1 and 3R2 animals
were analyzed at P14, each with littermate controls (white). � = p< 0.05; �� = p< 0.01; ��� = p< 0.001 by Tukey post-hoc test comparing the
indicated genotype with wild type. n = 3–9 animals per genotype. Box plots represent the median, first and third quartile, range, and outliers. B)
Western blots of brain lysates from 13R1 (at P0), 3R1, and 3R2 mutants (at 1 month of age) with littermate controls confirm the protein isoform
expression predicted by allele sequencing. Arrowhead indicates the specific γB2 band at the predicted size; asterisk indicates non-specific
background band of incorrect size present in adult samples only. C) Total γ-Pcdh protein levels were quantified using Li-Cor quantitative western
blotting, normalizing to GAPDH. Values from three samples per genotype were compared to littermate controls using student’s t-test with the
indicated p-values.
https://doi.org/10.1371/journal.pgen.1008554.g003
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We also verified that these mRNA expression levels were reflected at the protein level, utiliz-
ing a series of antibodies specific for particular γ-Pcdh protein isoforms [55]. Western blot
analysis of brain lysates from 13R1 neonates and 3R1 and 3R2 adults confirmed the presence
of the expected isoforms at the appropriate molecular weights: 13R1 brains expressed γA iso-
forms, γB2, and γC3, but not γC4, while 3R1 and 3R2 brains expressed γC3 and γC4, but not
γB2 or any γA isoforms (Fig 3B). We used quantitative western blotting to compare the levels
of total γ-Pcdh constant domain with littermate controls (Fig 3C). 13R1 mutants were indistin-
guishable from wild type littermates, while 3R1 and 3R2 mutants were significantly reduced
(despite the fact that differences did not reach statistical significance at the RNA level, Fig 3A).
Based on these analyses, we concluded that 13R1 homozygous mutants are not, in fact, com-
plete Pcdhg functional nulls, and that the similarity of their neonatally lethal phenotype to that
of nulls likely reflects the essential nature of a particular isoform lost in this line but present in
both 3R1 and 3R2; that is, γC4, as described below. Before testing this conclusion in detail, we
first asked whether the neonatal lethality of 13R1 was accompanied by cellular phenotypes pre-
viously described in Pcdhgdel/del null mice, and whether the viable 3R1 and 3R2 lines lacked
these phenotypes.
Excessive developmental neuronal apoptosis occurs in mutants exhibiting
neonatal lethality
Pcdhgdel/del mutants exhibit neonatal lethality with excessive cell death of interneurons in the
ventral spinal cord and brainstem, accompanied by reactive gliosis [31, 33, 37]. To ask if lethal-
ity in reduced diversity mutants was also accompanied by increased developmental apoptosis,
we analyzed cryosections from spinal cords at P0. Indeed, we found significant cell death in
13R1 homozygous mutants, but not 3R1 or 3R2 mutants (Fig 4). Staining of transverse sections
for the pan-neuronal marker NeuN revealed that 13R1 mutant spinal cords were grossly
smaller, with obvious reductions in cell number primarily in the ventral spinal cord, as
reported previously for Pcdhgdel/del null mutant neonates (Fig 4A–4C) [31, 33]. This was
accompanied by an increase in reactive astrocytes, revealed by GFAP labeling within the gray
matter (Fig 4D–4F), which we showed previously in null mice to be a response to neuronal
apoptosis [37]. Spinal interneurons derive from 6 dorsal (dI1-6) and 4 ventral (V0-3) domains
(reviewed by [56]); we used antibodies against two transcription factors, FoxP2 and Pax2, that
label distinct subsets of interneurons. We found significantly fewer FoxP2-positive and Pax2-
positive ventral interneurons in 13R1 mutants than in wild type littermates or 3R1 homozy-
gous mutants (Fig 4G–4Q). To confirm that cell loss resulted from excessive apoptosis as
observed in Pcdhg nulls, we assayed for cleaved caspase 3 (CC3), a marker of apoptotic cell
death, and found significantly more CC3-labeled profiles in 13R1 mutants than in wild type lit-
termates or 3R1 (Fig 4M–4O and 4R). An additional phenotype previously described in Pcdhg
null mutants is the clumping of parvalbumin-positive Ia afferent axon terminals around their
motor neuron targets in the ventral horn; this phenotype is worsened by, though not entirely
due to, increased interneuron apoptosis [36]. Again, we found that 13R1 mutants exhibited a
null mutant-like phenotype while 3R1 mutant Ia afferent projections appeared similar to those
of controls. (S4 Fig).
Increased cell death of many neuronal subtypes is also a hallmark of Pcdhg loss of function
in the retina, with retinal cell death occurring largely postnatally [10, 43]. To circumvent the
neonatal lethality of 13R1 mutants, we made compound heterozygous mutants with the condi-
tional loss of function allele Pcdhgfcon3 [31] crossed with Pax6α-Cre to restrict recombination
of this allele to the retina [57]. These mutants are referred to as 13R1/cRKO (for conditional
retinal knockout). Examination of immunostained retinal cross sections from 13R1/cRKO
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mutants at P14 revealed substantial thinning of the inner retina, including both cellular and
synaptic layers, compared to wild type (Fig 5A and 5B), whereas 3R2 mutant retinas were not
thinner (Fig 5C). As reported for Pcdhg null mutants [43], the retinal thinning in 13R1/cRKO
mice was not accompanied by obvious disorganization of neurite stratification within the
inner plexiform layer (Fig 5D–5I). To verify that this resulted from cell loss, we measured the
density of two amacrine cell types (tyrosine hydroxylase (TH)+ dopaminergic amacrine cells
and VGLUT3+ amacrine cells) and two retinal ganglion cell types (Melanopsin+ RGCs and
Fig 4. Spinal interneurons undergo excessive apoptosis in 13R1, but not 3R1 mutants. Cryosections from P0 spinal
cords were immunostained for the indicated markers (green; DAPI counterstain for nuclei, blue). NeuN staining in
cryosections from P0 spinal cords of (A) wild type, (B) 13R1 mutants, and (C) 3R1 mutants revealed that 13R1 mutant
cords were smaller with substantial loss of ventral interneurons. (D-F) Comparison of GFAP-positive astrocytes within
the ventral spinal cord showed reactive gliosis in (E) 13R1, but not in (D) wild type or (F) 3R1. Specific interneuron
populations were quantified, including (G-I,P) FoxP2+ and (J-L,Q) Pax2+ ventral interneurons. Both populations were
significantly reduced in 13R1 mutants compared to wild type or 3R1 animals (P, Q). The horizontal white line in J
indicates the divide used to quantify ventral interneurons. M-O) Staining for cleaved caspase 3 (CC3) reveals more
apoptotic cells in (N) 13R1 than in (M) wild type or (O) 3R1 mutants (quantified in R). Scale bar is 200 μm. �� = p< 0.01;
��� = p< 0.001 by Dunnett’s multiple comparison test comparing the indicated genotype with wild type. n = 32–48
hemicords total from 3 animals per genotype. Box plots represent the median, first and third quartile, range, and outliers.
https://doi.org/10.1371/journal.pgen.1008554.g004
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Brn3a+ RGCs) in whole-mount retinas from P14 animals. All four cell types were significantly
less numerous in 13R1/cRKO mutants than in wild-type littermates or in 3R1 or 3R2 homozy-
gous mutants, neither of which exhibited any abnormalities (Fig 6). Together our results show
that the excessive neuronal apoptosis and postnatal lethality observed in Pcdhg mutants does
not depend on isoform diversity per se.
Fig 5. Substantial loss of retinal thickness without layer disorganization in 13R1 mutants. A-C) Cryosections taken
in cross section through retinas of (A) wild type, (B) 13R1/cRKO, and (C) 3R2 mutants at two weeks of age were
immunostained for SV2 to label the synaptic layers (outer and inner plexiform layers; OPL, IPL) and DAPI to label the
inner and outer nuclear layers (ONL, INL) and retinal ganglion cell layer (RGL). The IPL and INL were both notably
thinner in 13R1/cRKO than in wild type or 3R2 mutants. This was not accompanied by disorganization of neuronal
subtype stratification within the IPL, as revealed by (D-F) Melanopsin and TH immunolabeling of ipRGCs and
dopaminergic amacrine cells, respectively, and (G-I) VGLUT3 and ChAT immunolabeling of glutamatergic amacrine
cells and starburst amacrine cells, respectively. Scale bar is 50 μm. Images are representative of at least 6 retinas per
genotype analyzed.
https://doi.org/10.1371/journal.pgen.1008554.g005
Reducing diversity in the Pcdhg gene cluster
PLOS Genetics | https://doi.org/10.1371/journal.pgen.1008554 December 26, 2019 12 / 32
Pcdhgc4 is the necessary and sufficient Pcdhg cluster gene for postnatal
viability
Having confirmed that the phenotypes of 13R1 resemble the complete deletion of the Pcdhg
cluster, in the second part of the study we turned to utilizing the novel CRISPR mutant mouse
lines to confirm which γ-Pcdh isoforms were critical. We noted that homozygous 3R1 mutants
survived and did not exhibit exacerbated apoptosis despite lacking expression of any func-
tional γA or γB isoforms, indicating that one or more of the C3-C5 isoforms must be critical.
Furthermore, 3R2 mutants survived and were phenotypically normal without a functional
Pcdhgc5 gene, whilst 13R1 homozygous mutants, which exhibited neonatal lethality and exac-
erbated neuronal apoptosis uniquely harbored frame-shifting mutations in Pcdhgc4 with no
Fig 6. Reduced retinal neuron numbers in 13R1 mutants. Whole mount retinas from two-week-old mice were immunostained to label neuronal subtypes, imaged en
face by confocal microscopy, and cell densities quantified. Analyzed cell types include (A-E) VGLUT3+ amacrine cells, (F-J) TH+ dopaminergic amacrine cells, (K-O)
Melanopsin+ ipRGCs, and (P-T) Brn3a+ RGCs. For all four of the subtypes assayed, densities were significantly reduced in 13R1/cRKO retinas compared to wild-type.
Densities were not reduced in either 3R1 or 3R2. Scale bar in D is 100 μm (for A-D); scale bar in S is 300 μm (for F-S). �� = p< 0.01; ��� = p< 0.001 by Tukey post-hoc
test comparing the indicated genotype with wild type. n = 6 retinas per genotype. Box plots represent the median, first and third quartile, range, and outliers.
https://doi.org/10.1371/journal.pgen.1008554.g006
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changes in expression level or coding sequence of either Pcdhgc3 or Pcdhgc5 (Fig 3, Table 1).
In a separate study, we have derived and are analyzing a CRISPR-targeted mouse line that spe-
cifically generated a Pcdhgc3 loss-of-function allele, and have found that they are viable and
fertile as adults (S5 Fig, D. Steffen, K.M. Mah, P.J. Bosch, A.M. Garrett, R.W. Burgess, and J.A.
Weiner, in preparation). Together with prior data indicating that mice lacking the entire
Pcdha and Pcdhb clusters are viable [5, 48], this suggests that Pcdhgc4 encodes the sole cPcdh
isoform essential for organismal survival. We generated two additional mouse lines to confirm
this conclusion.
First, we chose Pcdhgem8 from our list of mutants for cryorecovery (Table 1). This line har-
bored a large deletion from within exon A1 to within exon C3 identified by visual inspection
of the aligned reads from the original amplicon sequencing, as well as a 1 bp frame-shifting
deletion in exon C5. Upon cryorecovery, we generated homozygous mutants and verified
these mutations by linked-read whole genome sequencing (Fig 7A, S6A Fig). As only V exon
C4 was left intact, this strain was renamed Pcdhg1R1 (1R1 hereafter). These homozygous
mutants survived into adulthood and were fertile, with no overt differences from their wild
type litter mates. Both quantitative RT-PCR and western blot analyses reflected the expected
isoform expression, while levels of total γ-Pcdh were reduced at the mRNA and protein level
(Fig 7C, S7 Fig).
Second, we generated an entirely new mutant mouse line by specifically targeting Pcdhgc4
for CRISPR/Cas9-directed gene disruption. This resulted in a 13 bp frame-shifting deletion 3’
to the start codon (Fig 7B; S6B Fig). We named this new allele PcdhgC4KO (C4KO hereafter).
Homozygous C4KO mutants exhibited the same hunched posture, tremor, and inability to
nurse or right themselves observed in Pcdhgdel/del and 13R1 mutants and died shortly after
birth. Sanger sequencing confirmed that the analogous regions of the other Pcdhg V exons
were not disrupted in this line (S6B Fig), while western blot analyses verified that the other iso-
forms were produced as expected (Fig 7C). Together, these two additional mouse lines show
that mutation of Pcdhgc4 alone recapitulated the overt phenotype of losing the entire cluster,
whilst expression of this single γ-Pcdh isoform was sufficient to rescue viability, even when all
21 other Pcdhg isoforms were absent.
Pcdhgc4 is the crucial isoform for neuronal survival
To ask if these overt phenotypes of death vs. survival in C4KO and 1R1 mutants extended to
neuronal cell survival, we again analyzed spinal cords from P0 neonatal mutants. As expected
from their outward appearance, 1R1 homozygous spinal cords appeared grossly normal in
overall size and neuronal density (NeuN+ cells), with little if any reactive gliosis (GFAP+; Fig
8B and 8D). In contrast, C4KO mutant spinal cords were grossly smaller and exhibited clear
ventral interneuron loss (Fig 8A) accompanied by reactive gliosis (Fig 8C) that was essentially
identical to that observed in complete Pcdhg null mutants [31, 33] and 13R1 mutants (Fig 4).
Analysis of individual cell types revealed significant loss of FoxP2-labeled cells and Pax2-posi-
tive neurons in the ventral spinal cord of C4KO mutants (Fig 8E, 8G, 8K and 8L). Significant
reductions in 1R1 mutant cell density were observed, though they were much more modest
(Fig 8F, 8H, 8K and 8L). Consistent with this, there were significantly more CC3-positive neu-
rons in C4KO mutants than in 1R1 or WT neonates (Fig 8I, 8J and 8M). As expected, these
patterns of spinal interneuron survival corresponded to the presence (C4KO; S8A Fig) or
absence (1R1; S8B Fig) of aggregated Ia afferent terminals around motor neurons in the ven-
tral horn.
As 1R1 mutants survive into adulthood, we analyzed neuronal survival in the retina at 14
days of age and in adult. There was no indication of retinal thinning at either age. As above,
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Fig 7. Two further mouse alleles that indicate γC4 is the sole γ-Pcdh isoform necessary and sufficient for postnatal survival. A) A
schematic of the 1R1 allele illustrates a large deletion from the sgRNA guide site in exon A1 to that in exon C3, as well as a frame-shifting
insertion in exon C5 (red upward triangle). Only exon C4 remained intact. All mutations were verified by whole-genome sequencing. B)
C4KO mutants were made by targeting exon C4 only for CRISPR/Cas9 genome editing, resulting in a 13 base pair deletion (red downward
triangle). C) Western blot analyses on P0 cortex confirmed the protein expression expected from sequence analysis. Particularly, γC4 was
present in 1R1 mutants (arrowhead, specific lower band of expected size; asterisk indicates larger non-specific band) but absent in C4KO
animals, while all other isoforms analyzed were absent in 1R1 but present in C4KO. D) Total γ-Pcdh protein levels were quantified using Li-
Cor quantitative western blotting, normalizing to GAPDH. Values from three samples per genotype were compared to wild type controls
using a Dennett’s multiple comparison test with the indicated p-values.
https://doi.org/10.1371/journal.pgen.1008554.g007
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Fig 8. The isoform γC4 is necessary for normal neuronal survival. Cryosections from P0 spinal cords were immunostained for
the indicated markers (green; DAPI counterstain for nuclei, blue) A-B) Immunostaing for NeuN revealed grossly smaller spinal
cords and neuronal loss in C4KO mutants, but not 1R1 animals. C-D) This was accompanied by reactive gliosis in C4KO. E-H)
Interneuron subtypes were analyzed as in Fig 4 (E-F, FoxP2 and G-H, Pax2). K-L) Ventral interneurons were drastically reduced in
C4KO mutants; decreases in 1R1 mutants were statistically significant, but substantially more modest. I-J) Apoptosis was increased
in C4KO animals, but not in 1R1 mutants, as demonstrated by CC3 immunolabeling (quantified in M). N-Q) Whole mount retinas
from 1R1 mutants were assayed for neuronal loss at 2 weeks of age and in adult as in Fig 6. There were no reductions in (N)
VGLUT3+ amacrine cells, (O) TH+ dopaminergic amacrine cells, or (P) Melanopsin+ ipRGCs. Q) At 2 weeks of age, Brn3b
+ RGCs were also not reduced, but their density was significantly lower in adult retinas. R) Summary of phenotypes in the analyzed
strains. Mutations that disrupted Pcdhgc4 resulted in high levels of cell death (+++) and postnatal lethality, while mutations that
spared Pcdhgc4 resulted in little to no cell death and animal survival. Scale bar is 200 μm. � = p< 0.05; �� = p< 0.01; ��� =
p< 0.001 by Dunnett (spinal cord) or Tukey (retina) test comparing the indicated genotype with wild type. Wild type values in
K-M are represented from Fig 4. n = 36 hemicords total from 3 animals per genotype or n = 6 retinas per genotype. Box plots
represent the median, first and third quartile, range, and outliers.
https://doi.org/10.1371/journal.pgen.1008554.g008
Reducing diversity in the Pcdhg gene cluster
PLOS Genetics | https://doi.org/10.1371/journal.pgen.1008554 December 26, 2019 16 / 32
cell densities were calculated (in cells per mm2) for four cell types: dopaminergic amacrine
cells (TH+), VGLUT3+ amacrine cells, ipRGCs (Melanopsin+), and Brn3a+ RGCs (Fig 8O–
8R). The means of the cell densities were compared across genotype and age with a two-way
ANOVA followed by pairwise comparisons with a Tukey analysis. There was a significant
genotype effect in Brn3a+ cell density (p = 0.034), and a significant pairwise difference
between wild type animals at 2 weeks and 1R1 mutants in adult (p = 0.046). No other differ-
ences reached statistical significance. Therefore, neuronal survival was largely normal in 1R1
mutants, with any cell loss being very modest compared to mutants lacking γC4 (13R1/cRKO:
Fig 5, Fig 6; Pcdhg nulls: [43]).
PCDHGC4 is constrained in humans
With the number of human genomes and exomes that have been sequenced, it is possible to
test if variation occurs at the rate expected from random mutation. If predicted loss of function
(LOF) mutations (e.g., frame-shifts and premature stop codon insertions) within a given gene
are observed at lower rates than expected, it indicates that that gene is essential, and that loss of
function is not tolerated (referred to as “constraint”). To ask if specific cPcdh isoforms are con-
strained in the human population, we queried the Genome Aggregation Database (gnomAD,
Broad Institute), an aggregation of genomic variation across 141,456 human exomes and
whole genomes [58]. For each cPcdh isoform, the ratio of observed to expected (o/e) LOF
mutations was reported along with its 90% confidence interval (CI, vertical lines, Fig 9A and
9B). The suggested threshold for considering a gene under constraint is if the upper bound of
the 90% CI falls below 0.35 (red line, Fig 9A and 9B) [58]. Within the PCDHG locus, only
PCDHGC4 met this criterion (o/e = 0.14, 90% CI = 0.07–0.31, Fig 9A). Amongst the PCDHA
and PCDHB isoforms, only PCDHAC2, the specific isoform required in serotonergic neurons,
was constrained (o/e = 0.16, 90% CI = 0.09–0.34). Thus, consistent with our analysis of the
orthologous gene in our allelic series of mice, PCDHGC4 is likely also essential in humans.
Discussion
The 22 γ-Pcdhs comprise a diverse family of cadherin superfamily adhesion molecules with
multiple distinct functions in distinct cell types. Extant data suggest three possible models for
the role of isoform diversity: (1) a model of diversity where many isoforms are required for a
given function; (2) a model of redundancy in which any single isoform (or small subset of iso-
forms) can serve a given function; and (3) a model of isoform specificity where one specific iso-
form (or small subset of isoforms) is strictly required for a given function. Here, we used a
CRISPR/Cas9 strategy to reduce γ-Pcdh isoform diversity in an unbiased fashion, creating a
new allelic series of mouse strains. In the course of analyzing several new Pcdhg alleles, we dis-
covered that the control of neuronal survival and postnatal viability is best described by the
third model. We found–surprisingly, given its inability to reach the cell surface and mediate
homophilic adhesion without other cPcdh cis-interaction partners–that γC4 is the sole neces-
sary and sufficient isoform among the γ-Pcdhs. We do not rule out the possibility that mem-
bers of the α and β cluster could contribute to this function by acting as essential co-receptors
or carriers. The new lines we report here will be instrumental for future studies delineating the
importance of isoform diversity to other γ-Pcdh functions including self-avoidance and den-
drite arborization.
Generation of a new allelic series with reduced Pcdhg isoform diversity
Our strategy was to inject Cas9 mRNA along with 20 individual sgRNAs targeting each of the
Pcdhg V exons simultaneously. By screening G1 offspring from many founders, we collected
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an array of mutants with distinct V exon mutation patterns, ranging from a single isoform dis-
rupted (21 intact) to 21 isoforms disrupted (1 intact), all of which were cryopreserved. Each
isoform was disrupted in at least one mutant line (Table 1). Furthermore, there was evidence
of double-stranded breaks at each sgRNA site identifiable as indels or junctions between guide
sites. Not all guide sites were equally represented by mutations in the allelic series (e.g., γA1
was targeted in 16/26 new alleles, while γA11 was targeted in 3/26). This could reflect differ-
ences in the efficiencies of individual guides (only γC3 and γC4 sgRNA were tested individu-
ally) or differential accessibility of target sites. Our G1 screening was done by Illumina
sequencing of a custom amplicon array. This technique was effective for identifying indels
Fig 9. PCDHGC4 is constrained in humans. The gnomAD database (https://gnomad.broadinstitute.org/; [58]) was
queried for each cPcdh isoform to determine the extent to which loss-of-function (LoF) mutations were tolerated
within the human population. A) The ratio of observed to expected (o/e) LoF mutations (y-axis) surrounded by its
90% CI is plotted for each PCDHG isoform (x-axis). PCDHGC4 (red circle) is the only isoform in which the upper
bound of the 90% CI falls below 0.35 (red line), indicating constraint. B) LoF o/e (y-axis) is plotted for each isoform
from the PCDHA and PCDHB cluster (x-axis). PCDHAC2 is the only constrained isoform (red circle).
https://doi.org/10.1371/journal.pgen.1008554.g009
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within each individual amplicon (e.g., smaller indels at each guide site), but was not exhaustive
in identifying rearrangements between guide sites, even when both sides of the junction were
predicted to be recognized by the amplicon array primers. This could be due to the new DNA
sequence: 1) being difficult to amplify within the array, and therefore not sequenced; 2) not
being accurately aligned to the reference genome; or 3) not being identified as a new junction
by the bioinformatic algorithm BreaKmer. Indeed, some junctions that were not recognized
by BreaKmer were clearly identified by visual inspection of the sequence alignments within
IGV as paired reads mapping to two different exons (S1 Table). Those identified in two differ-
ent mutant lines– 3R1 and 1R1 –were confirmed by whole genome sequencing. It is thus likely
that many of the cryopreserved lines not yet recovered and made homozygous harbor addi-
tional mutations to those described here from the initial analysis (Table 1, S1 Table). We
focused on founders generated from the HI concentration of sgRNA (50ng). It is possible that
founders from the MID or LO injection concentrations are more likely to harbor discrete
indels and less elaborate rearrangements, but with lower total targeting efficiency. However,
very few founders from the LO concentration were identified with any mutation in the initial
screen, and alleles generated from the MID concentration still contained multiple rearrange-
ments (e.g., Pcdhgem33, S1 Table). We suggest that future studies targeting multiple sites within
a relatively small region balance these concerns. We would, however, recommend methods
other than amplicon sequencing to identify rearrangements between guide sites, such as tar-
geted long-read sequencing [59].
One concern when using a pooled sgRNA approach such as ours is the compounding of
potential off-target mutations. To assess this, we sequenced the top 95 predicted off-target sites
in G1 offspring by amplicon sequencing. We did not identify indels attributable to Cas9 activ-
ity at any of these sites. While not exhaustive, this analysis is consistent with recent studies sug-
gesting that off-target mutations from CRISPR/Cas9 are relatively rare in mouse model
production[60–62]. To further confirm the specificity of our CRISPR/Cas9 targeting, we per-
formed whole genome sequencing on homozygous mutants from four lines at least three gen-
erations after G1. Here, we were particularly concerned with the closely linked and highly
similar protocadherins encoded by the two adjacent gene clusters (Pcdha and Pcdhb) as well as
Pcdh1 and Pcdh12, non-clustered protocadherins located within 450 kb of the Pcdhg cluster.
There were no indels or rearrangements identified within any of these genes. We conclude
that, at the resolution assayed here, off-target mutations do not contribute to our results. This
conclusion is bolstered by the segregation of postnatal and neuronal survival phenotypes
observed across multiple mouse lines: the two lines harboring frame-shifting mutations in
Pcdhgc4 (13R1 and C4KO, generated separately with distinct methodologies) died and exhib-
ited similarly exacerbated neuronal apoptosis, while the two mouse lines in which Pcdhgc4 was
untouched (3R1) or harbored a small in-frame deletion (3R2) survived and exhibited normal
neuronal survival. The fact that mice harboring an additional allele (1R1) in which Pcdhgc4 is
the only remaining functional isoform are viable and exhibit only mild neuronal survival alter-
ations further supports the specificity of CRISPR targeting.
Isoform choice in the Pcdh gene clusters is regulated by CCCTC-binding factor (CTCF)
and cohesin, which bind directly to a conserved sequence element (CSE) in each individual V
exon promoter [63–65]. These proteins organize DNA loops, bringing the promoters of
expressed isoforms into proximity with an enhancer region 3’ to the constant exons [66].
CTCF/cohesin complex binding is restricted by promoter methylation laid down during
embryogenesis by the methyltransferase Dnmt3b. Indeed, in the absence of Dnmt3b, many
more cPcdh isoforms were expressed by each neuron [67]; conversely, in CTCF knockout fore-
brain neurons, expression of nearly all cPcdh genes was markedly reduced [68]. Here, we ana-
lyzed the isoform expression in cerebral cortex from four new Pcdhg mutant strains using
Reducing diversity in the Pcdhg gene cluster
PLOS Genetics | https://doi.org/10.1371/journal.pgen.1008554 December 26, 2019 19 / 32
qPCR. In the Pcdhg cluster, indels or other genomic DNA junctions that allowed splicing from
V exons to the constant exons resulted in expressed transcripts, while expression from iso-
forms deleted from the genome or inverted were undetectable, as expected (Fig 3, S7 Fig). The
lone exception was the 3’-most isoform, γC5, which was significantly reduced in 1R1 mutants
which harbored a single base pair insertion in the Pcdhgc5 variable exon (S7 Fig). We also ana-
lyzed select isoforms from the Pcdha and Pcdhb clusters. Here, large deletions in the 5’ end of
the Pcdhg cluster resulted in significantly higher expression from the 3’ Pcdhb isoforms (β11,
β15, and β22, S3 Fig, S7 Fig). This was most pronounced in 1R1 mutants, which harbor the
largest deletion in the Pcdhg cluster, but was not detected in 13R1 mutants, which have the
smallest deletion of the mutants assayed. This is likely due to regulatory elements within DNa-
seI hypersensitive sites HS16-20, located 3’ to the Pcdhg cluster, that are essential for expression
from the Pcdhb cluster [69]. The movement of these elements closer to the Pcdhb cluster in the
1R1, 3R1, and 3R2 alleles is likely responsible for the increased expression observed. Consis-
tent with this interpretation, it has previously been reported that moving Pcdha isoforms closer
to regulatory elements located between the Pcdha and Pcdhb cluster (HS7 or HS5-1) by delet-
ing intervening exons resulted in their increased expression [70]. Importantly, this increased
expression of Pcdhb cluster genes cannot be responsible for the viability of the 1R1, 3R1, or
3R2 mouse lines: similar Pcdhb overexpression was reported previously in Pcdhgdel/del animals,
which nevertheless die at birth [34].
Pcdhgc4 is the essential isoform for neuronal survival and postnatal
viability
Previous interrogations of Pcdhg isoform diversity either deleted two sets of three V exons
(A1-A3 or C3-C5) [34]or drove overexpression of a single isoform from a transgene [40, 42,
44, 45]. Our new series of mutants, including both those initially analyzed and the many that
remain cryopreserved, will allow for a finer dissection of the role of isoform diversity and the
identification of potential isoform-specific functions. Chen et al. [34] showed that mice lacking
γC3-C5 exhibited neonatal lethality and exacerbated spinal interneuron apoptosis similar to
that of Pcdhg null mutants; in contrast, mice lacking A1-A3 were viable and outwardly normal.
Our new results indicate that γC4 is, in fact, the sole essential isoform for neuronal survival
and postnatal viability, indicating that loss of this isoform was responsible for the lethality
observed in ΔC3-5 mice [34]. This is particularly surprising, as the γC4 isoform is peculiar in
several ways. Cell aggregation experiments in the K562 suspension cell line indicate that γC4,
uniquely among γ-Pcdhs, cannot mediate trans homophilic binding on its own, at least in het-
erologous cells in vitro. Like the α-Pcdhs, it requires interaction with carrier isoforms (either
other γ- or β-Pcdhs) to reach the cell membrane [18], possibly because EC6 of γC4 inhibits
surface delivery and the formation of cis-homodimers [17, 18]. This raises the novel possibility
that the postnatal viability and largely (though not entirely) retained neuronal survival
observed in 1R1 mutants, in which γC4 is the only functional γ-Pcdh isoform, may reflect
functions for this protein in cellular compartments other than the plasma membrane. Alterna-
tively, γC4 may reach the membrane (e.g., escorted by β-Pcdhs) and participate in homophilic
interactions that trigger intracellular signaling pathways specific to the γC4 VCD, which
remain to be identified. Precedence for this latter possibility comes from our recent finding
that the VCD of γC3 can, uniquely amongst γ-Pcdhs, bind to and sequester Axin1 at the mem-
brane, which leads to suppression of some components of the Wnt signaling pathway [49].
Thus, while the downstream mechanisms through which γ-Pcdhs promote neuronal sur-
vival remain unknown, our findings suggest that either protein interactions specifically medi-
ated by γC4, or a unique localization for this isoform, will be involved. In 1R1 mutants, γC4
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alone was not entirely sufficient for normal neuron number in the spinal cord or retina (Fig 8).
This could be explained potentially by the significantly reduced expression levels of γC4 (and
thus of total γ-Pcdh proteins) in these mutants (Fig 7C, S5 Fig), or it could indicate that other
cPcdh isoforms contribute to survival of some neuronal subsets in a collaborative, if not strictly
essential, manner. Consistent with this second possibility, cell death phenotypes observed in
Pcdhg mutants were made more severe by additional disruption of the Pcdha and Pcdhb clus-
ters, despite the fact that Pcdha or Pcdhb disruption did not increase cell death when Pcdhg
remained intact [10, 48]. In any case, our genetic interrogation of the Pcdhg gene cluster clearly
demonstrates that γC4 is the only γ-Pcdh isoform strictly necessary for neuronal survival and
postnatal viability. Consistent with this, the orthologous PCDHGC4 is the only PCDHG gene
(and, along with PCDHAC2, one of only 2 clustered Pcdh genes overall) that is constrained in
humans, thus indicating an essential role conserved throughout mammalian evolution that is
of potential clinical relevance. In this respect, the critical next step will be to elucidate the
unique protein-protein interactions and intracellular signaling pathways in which γC4 partici-
pates during the development of the nervous system.
Materials and methods
Ethics statement
All procedures using animals were performed in accordance with The Guide for the Care and
Use of Laboratory Animals and were reviewed and approved by the Institutional Animal Care
and Use Committee of The Jackson Laboratory (approval number 1026) and The Institution
Animal Care and Use Committee of the University of Iowa (approval number 8011375), The
Institution Animal Care and Use Committee of Wayne State University (approval number 18-
06-0685). All animals were euthanized by CO2 asphyxiation, consistent with the recommenda-
tions of the American Veterinary Medical Association (AVMA) 2013 Guidelines on
Euthanasia.
Mouse strains
All animals were housed in the research animal facility either at The Jackson Laboratory, The
University of Iowa, or Wayne State University under standard housing conditions with a 12 h/
12 h light/ dark cycle and food and water ad libitum. All procedures using animals were per-
formed in accordance with The Guide for the Care and Use of Laboratory Animals and were
reviewed and approved by the Institutional Animal Care and Use Committee at each respec-
tive institution. All experiments included a mix of male and female animals. Previously
described animals include Pcdhgfcon3 [31] and Pax6α-Cre [57]. The newly generated reduced
Pcdhg diversity mutants are cryopreserved at The Jackson Laboratory (Stock numbers listed in
S3 Table).
Generation of Pcdhg reduced diversity mutants
Guide RNA (sgRNA) sequences were designed to target the near 5’ regions to the start codons
of each variable exon (S4 Table). Guides were designed using the tool at crispr.mit.edu and
were analyzed using RGEN tools to minimize off target sites and to maximize the likelihood of
frameshifting mutations [71–73]. 20 total guides were synthesized (IDT), as exons B4 and B5
had a high level of 5’ homology, as did exons B6 and B7. Guides were received lyophilized,
resuspended in water, mixed in equal parts, then lyophilized again. This mixture was diluted
and resuspended with S. pyogenes Cas9 mRNA to generate three guide concentrations: 50 ng/
μl for each guide, 10 ng/μl for each guide, or 5 ng/μl for each guide (HI, MED, LO,
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respectively). In each dilution, Cas9 mRNA was present at a concentration of 100 ng/μl. These
mixtures were microinjected into C57BL/6J zygotes, which were subsequently implanted into
pseudopregnant female C57BL/6J mice. 123 embryos injected with the HI concentration were
transferred to 6 females, 152 at MED transferred to 8 females, and 123 at LO to 6 females.
The resulting live founders (16 HI, 34 MED, 50 LO) were screened by PCR and Sanger
sequencing (primers in S5 Table). There were three iterations of screening. First, we chose 7
exons distributed across the locus for PCR amplification and Sanger sequencing in 100 live
founders. Heterozygous and homozygous indels were identified by analyzing the sequence
traces, and 15 founders were found to harbor some mutation. 50 of the 100 founders were
from the LO injection condition. No mutations were found in the first round of screening in
these animals, and they were not analyzed further. In the second round of screening, the 35
remaining founders were analyzed for indels at the other 15 exons. In the third round, they
were screened for rearrangements between exons by PCR with single forward primers mixed
with pooled reverse primers. PCR products detected above background level were purified and
sequenced using the forward primer. Mice carrying any mutation detected in any round of
screening were bred for one generation with C57BL/6J animals. The resulting G1 offspring
were screened by amplicon sequencing. Males were prioritized when available for ease of
sperm cryopreservation.
To generate PcdhgC4KO mice, only sgRNA complimentary to exon C4 was microinjected
(50 ng/μl, S4 Table) along with Cas9 mRNA (100 ng/μl). Of the resulting 16 live founders, 9
contained mosaic indels. 3 founders were crossed with C57BL/6J, one of which transmitted a
13 bp deletion. These mice were crossed to homozygosity, and all 22 variable exons were
screened by PCR and Sanger sequencing to verify that only the Pcdhgc4 exon was disrupted.
Screening by amplicon sequencing
A TruSeq Custom Amplicon 1.5 assay was designed with Illumina DesignStudio. The amplicon
length was 250 bp, 201 bp of which corresponded to target sequence. 153 targets were covered by
225 amplicons for a cumulative target length of 31,721 bp. Target regions were chosen to be cen-
tered at the sgRNA sites, the analogous sites in the variable exons in Pcdha and Pcdhb, and 95 pre-
dicted potential off-target sites. The target coordinates are listed in S1 File. Genomic DNA was
extracted using the DNeasy 96 Blood & Tissue Kit (Qiagen) from 94 G1 animals and processed
along with a C57BL/6J wild type control and a negative control. Libraries were constructed using
the TruSeq Custom Amplicon (Illumina) Library prep kit. Briefly, custom probes were hybridized
to the flanking region of interest in gDNA, DNA polymerase extended across the target region,
and unique barcodes and sequencing primers are added by PCR. Libraries were pooled and
sequenced on a MiSeq instrument from Illumina with paired-end reads, 150 bp long.
Sequences were matched to samples by barcode and aligned to the target regions (Base-
Space, Illumina). Variants were called using Genome Analysis Toolkit (GATK) [52]. As
CRISPR/Cas9 mediated NHEJ events result in small to medium sized indels, but not SNPs
[74], we focused on indels that exceeded the following thresholds: QUAL� 850; DP� 90;
QD� 5. We also filtered out indels detected in the wild type C57BL/6J control, as these reflect
discrepancies from the reference genome. Subsequent whole genome sequencing confirmed
these mutations in the Pcdhg locus, but not potential off-target mutations expected to be linked
(e.g., Pcdhb7). Furthermore, one mutation that did not exceed our threshold was detected by
whole genome sequencing (A12 in Pcdhgem35). Therefore, S1 Table summarizes mutations
detected in the Pcdhg locus above and below the threshold, as indicated.
Because of the pooled amplicon reaction, we reasoned that large rearrangements between
guide sites could be detected by amplicon sequencing if enough sequence remained on either
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side of the junction. To find these junctions we used BreaKmer [53]. We were able to detect
some of these junctions with BreaKmer, but subsequent whole genome sequencing revealed
rearrangements missed by BreaKmer in each sequenced mouse line. In some cases, this could
be because deletions extended beyond the amplicon site on one or both sides of the junction.
However, many junctions were flanked by enough amplicon sequence to expect them to be
detectible in this data set. Indeed, by visually analyzing the read alignments in the Integrative
Genomics Viewer (IGV, Broad Institute) we were able to find some of these junctions when
mating paired-end reads mapped to different exons (S1B Fig). We used this approach to iden-
tify additional junctions in the cryopreserved mouse lines as indicated in S1 Table.
Whole genome sequencing
Genomic DNA was isolated from homozygous mutants using the DNA Extraction from Fresh
Frozen Tissue protocol (10X Genomics). Briefly, nuclei were isolated from tissue, lysed using
proteinase K, then DNA purified using magnetic beads. Linked-read whole genome libraries
were constructed using the Genome Chip Kit v2 (10X Genomics). Briefly, high molecular
weight DNA was partitioned into Gel Bead-In-EMulsions (GEMs) where unique barcoded
primers were added to individual molecules of DNA. After the GEMs were dissolved, Illumina
specific sequencing primers and barcodes were added by isothermal amplification, then library
construction was completed via end repair, a-tailing, adapter ligation, and amplification.
Libraries were sequenced on a HiSeq X (Illumina) by Novogene (Sacramenta, CA) with 150 bp
paired-end reads. Sequences were aligned using the Long Ranger analysis pipeline from 10X
Chromium and visualized in Loupe (10X Genomics) or IGV (Broad Institute). Paired-end
reads were used to find NHEJ junctions between guide sites, while reads spanning the junc-
tions were analyzed to uncover the specific sequences of these junctions.
Data deposition
All Illumina sequencing data is available at the Sequence Read Archive (SRA) with the acces-
sion number PRJNA562238. Analysis outputs are at Mendeley with DOI: 10.17632/
yhn7dpmv6v.1
Quantitative RT-PCR
RNA was isolated from cerebral cortex of animals at P0 (13R1 mutants and littermate controls)
or 2–12 weeks of age (other mutants and littermate controls) using Trizol reagent. Five μg of
RNA per sample was used to make cDNA using Superscript III (Invitrogen) according to the
manufacturers protocol. qPCR was performed in triplicate (technical replicates) using primers
listed in S2 Table with SYBR Green PCR Master Mix. The relative abundance of each tran-
script was calculated using the ΔΔCt method, normalized to GAPDH and littermate controls.
Briefly, cycle thresholds (Ct) were averaged across three technical replicates and the Ct of sam-
ple-matched GAPDH was subtracted (ΔCt). These ΔCt values were subtracted from the aver-
age ΔCt control value within litters (ΔΔCt), and the relative normalized expression calculated
as 2^(ΔΔCt). The relative levels of each transcript in controls, 3R1, and 3R2 mutants were
compared using an ANOVA with Tukey post-hoc tests. 13R1 and 1R1 mutants were compared
with littermate controls for each transcript using a t-test.
Western blotting
Whole brains at P0 or adult ages (3–8 months) were homogenized in RIPA buffer (0.1% SDS,
0.25% sodium deoxycholate, 1% NP-40, 150 mM NaCl, 50 mM Tris-HCl, pH 7.4, 5 mM NaF)
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plus protease inhibitors (Roche Mini cOmplete) using a Dounce homogenizer and a Wheaton
overhead stirrer. The lysate was centrifuged at 16,000 X g for 15 min at 4˚C to remove cell
debris and proteins were quantified using a BCA assay kit (Pierce/Thermo Scientific). Forty μg
of protein was resolved on Mini-PROTEAN TGX precast 7.5% SDS-PAGE gels (Bio-Rad) and
proteins were transferred to a nitrocellulose membrane using the Bio-Rad Trans-Blot Turbo
Transfer System. Membranes were blocked using 5% skim milk for 1 hour and incubated with
the primary antibody in buffer (2.5% BSA in TBS-T (Tris buffered saline with 0.1% Tween-20)
overnight at 4˚C. The following day, membranes were washed using TBS-T and incubated in
HRP-conjugated secondary antibody for 1 hour. Membranes were washed, developed using
the SuperSignal West Pico ECL reagents (Thermo Scientific), imaged using a Li-Cor Odyssey
Fc Imaging system, and quantified using Li-Cor software. Levels in each lane were normalized
to GAPDH.
Immunofluorescence
Tissues were processed and stained as described previously [29, 31]. Briefly, neonatal spinal
columns were removed and fixed by immersion in 4% paraformaldehyde (PFA) for four hours
at 4˚ C, followed by extensive washing in PBS and cryopreservation in 30% sucrose. Eyes were
enucleated and dissected to remove the cornea and lens, then fixed overnight by immersion in
4% PFA at 4˚ C followed by cryopreservation in 30% sucrose. Tissue was embedded in OCT
(Sakura-Finetek) and sectioned with a cryostat onto positively charged Superfrost Plus slides
(Fisher Scientific). After blocking in 2.5% bovine serum albumin with 0.1% Triton-X-100 in
PBS, primary antibodies were incubated on the slides overnight at 4˚ C in a humidified cham-
ber, followed by secondary antibodies for 1 hour at room temperature. Whole mount retinas
were stained free floating in primary antibody diluted in blocking solution with 0.5% Triton-
X-100 for 48–72 hours, and in secondary antibody for 24 hours. Sections were counter-stained
with DAPI (4’,6-diamidino-2-phenylindole), prior to mounting with Fluoro-Gel mounting
media (Electron Microscopy Services #17985–11).
Antibodies
Primary antibodies used included the following: Guinea pig anti-VGLUT3 (1:10,000, Milli-
pore), sheep anti-tyrosine hydroxylase (1:500, Millipore), rabbit anti-melanopsin (1:10,000,
ATS), mouse anti-Brn3a (1:500, Millipore), goat anti-choline acetyltransferase (1:500, Milli-
pore), mouse anti-NeuN (1:500, Millipore), mouse anti-GFAP (1:500, Sigma), rabbit anti-
FoxP2 (1:4000, Abcam), rabbit anti-Pax2 (1:200, Zymed), rabbit anti-cleaved caspase 3 (1:100,
Cell Signaling Technologies), mouse anti-parvalbumin (1:500, Sigma), and mouse anti-
GAPDH (1:500, Abcam). Mouse monoclonal antibodies against γ-Pcdh proteins used for
western blots (1:500–1:1000) were generated by NeuroMab in collaboration with the Weiner
laboratory [55] and obtained from Antibodies, Inc.: N159/5 (detecting an epitope in constant
exon 1 or 2 and thus all 22 γ-Pcdh isoforms); N144/32 (detecting all γA subfamily isoforms);
N148/30 (specific for γB2); N174B/27 (specific for γC3). A rabbit polyclonal antibody raised at
Affinity BioReagents against the peptide sequence VAGEVNQRHFRVDLD (within EC1)
from murine γC4 was also used for western blotting (1:1000). Secondary antibodies were con-
jugated with Alexa-488, -568, or -647 (1:500, Invitrogen) or HRP (1:1000–1:5000, Jackson
Immunoresearch).
Image quantification
Control and mutant spinal cords were imaged using epifluorescence at equivalent thoraco-
lumbar locations using a Leica SPE TCS confocal microscope and captured with Leica
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Application Suite software. From the resulting images, cell counts were performed using Cell
Counter plugin in Fiji image analysis software [75]. For FoxP2 and CC3 analysis, all immuno-
reactive cells were counted per hemicord from 12 hemicords per animal and at least 3 animals
per genotype. For Pax2 analysis, all interneurons ventral to the central canal were quantified
and compared. Values for wild type and mutant genotypes were compared using One-way
ANOVA with Dunnett’s multiple comparison test. Sample size was based on prior studies, as
effective group sizes were known [31].
Whole mount retinas were imaged by confocal microscopy. In the resulting image stacks,
cell density was measured using the Cell Counter plugin in Fiji image analysis software [75].
Values from at least two fields per retina, sampled from different regions midway between the
center and periphery (technical replicates), were averaged. These averaged values from at least
six retinas per genotype (biological replicates) were compared using an ANOVA with Tukey
post-hoc tests. Sample size was based on prior studies, as effective group sizes were known.
Retinas were analyzed at 2 weeks of age, with the exception of 1R1 mutants and littermate con-
trols, which were analyzed at 2 weeks and adult (3–6 months of age). Here, values were com-
pared using a two-way ANOVA with age and genotype as independent variables, followed by
Tukey pairwise comparisons.
All p-values are listed in S3 File.
gnomAD database analysis
For each cPcdh isoform in human, the gnomAD browser was queried (gnomAD.
broadinstitute.org; [58]) and the ratio of observed to expected (o/e) loss of function variants
was recorded along with its 90% confidence interval.
Supporting information
S1 Fig. Workflow for identifying mutations with 3R1 as an example. A) PCR from genomic
DNA in 3R1 homozygous mutants compared with wild type, using primer pairs spanning
each sgRNA target site. PCR products were either absent or abnormal in size from more exons
than predicted by the custom amplicon sequencing analysis. B) Amplicon sequencing reads
from a heterozygous 1R1 mutant were aligned to the mouse genome and visualized in the Inte-
grated Genome Viewer (IGV) with paired-end reads highlighted. In this example, multiple
read pairs map with one end in exon A1 and the other in exon A4, indicating a junction
between A1 and A4 that was not detected by BreaKmer. C) Linked-read whole genome
sequencing was performed on DNA from a homozygous 3R1 mutant. The matrix represents
the locations of mapped reads with common barcodes, indicating that they originated from
common DNA fragments within a microfluidic droplet. The Pcdhg locus is presented on the X
and Y axes, revealing three large deletions including the deletion resulting in the A1-A4 fusion
found in B. D). Linked-read sequencing also revealed that Anp32a coding sequence incorpo-
rated into the Pcdhg locus, as reads mapping to its exons (but not introns) had barcodes in
common with those mapping to Pcdhg (Anp32a is on the Y axis, Pcdhg on the X axis).
(TIF)
S2 Fig. Linked-read whole genome sequencing of two further Pcdhg mutant lines. 10X
Chromium linked-read sequencing results from (A) 13R1 and (B) 3R2 mutants demonstrate
normal coverage through the Pcdha and Pcdhb clusters (upper panel), but coverage gaps
where sequence was deleted in the Pcdhg locus (upper and lower panels). Short reads with the
same barcode (i.e., from the same initial larger fragment) are connected on the matrix in the
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lower panel. Actual read sequences were used to identify junctions.
(TIF)
S3 Fig. Large deletions in Pcdhg increased mRNA expression from the 3’ end of Pcdhb.
Quantitative real-time PCR of cDNA reverse-transcribed from RNA isolated form cerebral
cortex from 13R1 mutants (red), 3R1 mutants (blue) and 3R2 mutants (green) demonstrated
no change in isoform expression from the Pcdha cluster genes analyzed. Pcdhb isoforms at the
3’ end of the cluster were increased in mutants with large deletions in Pcdhg (i.e., in 3R1 and
3R2 mutants, but not in 13R1 mutants). � = p< 0.05; �� = p< 0.01 by Tukey post-hoc test
comparing the indicated genotype with wild type. n = 3–9 animals per genotype. Box plots rep-
resent the median, first and third quartile, range, and outliers.
(TIF)
S4 Fig. Aggregation of Ia afferent axon terminals in mutants with interneuron apoptosis.
Parvalbumin staining of proprioceptive Ia afferent axons in spinal cord sections from P0 A)
wild type, B) 13R1 homozygous mutants, and C) 3R1 homozygous mutants reveals axon ter-
minal clumping in 13R1, but not 3R1 or wild type animals.
(TIF)
S5 Fig. Pcdhgc3 homozygous mutants survive at expected ratios. A) CRISPR/Cas9 targeting
of Pcdhgc3 only resulted in a 13 bp deletion in the PcdhgC3KO allele (referred to as C3KO here).
B) Tail genotyping PCR spanning the deletion was used to identify wild type, heterozygous,
and homozygous mutants. C) Homozygous C3KO mutants survive in numbers not signifi-
cantly different from the expected Mendelian ratio (n = 118 offspring from 18 litters).
(TIF)
S6 Fig. Confirmation of 1R1 and C4KO mutations. A) 10X Chromium linked-read sequenc-
ing results from 1R1 homozygous mutants demonstrates normal coverage through the Pcdha
and Pcdhb clusters (upper panel), but a large gap between Pcdhga1 and Pcdhgc3 (upper and
lower panels). Short reads with the same barcode (i.e., from the same initial larger fragment)
are connected on the matrix in the lower panel. Actual read sequences were used to identify
the junction. B) Sanger sequencing was performed on PCR from genomic DNA from C4KO
homozygous mutants. A frame-shifting 13 bp deletion was identified at the guide site in
Pcdhgc4, but no mutations were found in any of the other isoforms (Pcdhgc3 and Pcdhgc5 are
shown here, all other isoforms were also sequenced).
(TIF)
S7 Fig. Quantitative RT-PCR from 1R1 mutants. A) Quantitative real-time PCR of cDNA
reverse-transcribed from RNA isolated form cerebral cortex from 1R1 mutants (gray) com-
pared to control (white) demonstrated no change in isoform expression from the Pcdha clus-
ter. Expression of Pcdhb isoforms at the 3’ end of the cluster was increased in 1R1 mutants,
consistent with the effect from large deletions in 3R1 and 3R2 mutants. B) Expression of the
Pcdhg cluster reflected genomic mutations, including expression from the γA1-γC3 fusion.
γC5 isoform expression was significantly reduced (disrupted by 1 base pair insertion), and
total γ-constant expression was reduced by half. � = p< 0.05; �� = p< 0.01; ��� = p< 0.001 by
student’s t-test. n = 3 animals per genotype. Box plots represent the median, first and third
quartile, range, and outliers.
(TIF)
S8 Fig. γC4 is necessary and sufficient among γ-Pcdh isoforms for normal Ia afferent ter-
minal targeting. A) Parvalbumin staining in spinal cord sections from P0 C4KO mutants
revealed aggregation of proprioceptive Ia afferent axons comparable to that observed in null
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animals or in 13R1. B) Conversely, 1R1 homozygous mutants exhibited normal terminal mor-
phology similar to wild type, 3R1, and 3R2 pups.
(TIF)
S1 Table. Methods used to identify mutations. Mutations were identified by analyzing
sequence results from the custom amplicon using GATK (blue = above threshold or
purple = below threshold), Breakmer (orange), or visual inspection of aligned reads (yellow),
or by analyzing whole genome sequencing (green). Numbers indicate the size of insertion
(positive numbers) or deletion (negative numbers). Dashed lines indicate large scale rear-
rangements or deletions between the indicated exons.
(PDF)
S2 Table. Primers used for quantitative RT-PCR.
(PDF)
S3 Table. Summary of new alleles created here.
(PDF)
S4 Table. sgRNA sequences.
(PDF)
S5 Table. Primers used to amplify target regions of Pcdhg variable exons.
(PDF)
S1 File. Genomic coordinates of custom amplicon sequencing targets.
(CSV)
S2 File. Mutation details. Tab 1 includes GATK calls for mutations detected by custom ampli-
con sequencing. Tab 2 includes BreaKmer calls. Tab 3 includes primary protein sequence for
all mutant isoforms from the lines analyzed in detail.
(XLSX)
S3 File. p-values from all analyses.
(XLSX)
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